FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2940616984> ?p ?o ?g. }

• W2940616984 abstract "You have accessJournal of UrologyProstate Cancer: Basic Research & Pathophysiology II (MP68)1 Apr 2019MP68-15 TARGETING STEROID SULFATASE SUPPRESSES ANDROGEN RECEPTOR SIGNALING AND TUMOR GROWTH IN CRPC Chengfei Liu, Liangren Liu, Cameron Armstrong*, Joy Yang, Wei Lou, Pui-Kai Li, Christopher Evans, and Allen Gao Chengfei LiuChengfei Liu More articles by this author , Liangren LiuLiangren Liu More articles by this author , Cameron Armstrong*Cameron Armstrong* More articles by this author , Joy YangJoy Yang More articles by this author , Wei LouWei Lou More articles by this author , Pui-Kai LiPui-Kai Li More articles by this author , Christopher EvansChristopher Evans More articles by this author , and Allen GaoAllen Gao More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000557030.32825.dfAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract INTRODUCTION AND OBJECTIVES: Steroid sulfatase (STS) is a key enzyme that catalyzes the hydrolysis of DHEAS to the biologically active DHEA. DHEA is further metabolized to the active androgens that bind the androgen receptor (AR) leading to cell proliferation. STS plays important roles in hormone-responsive malignant growth including prostate cancer. The aim of this study is to determine the role of STS in AR signaling and to explore the potential of targeting STS overcoming castration resistance in prostate cancer. METHODS: Sensitivity of prostate cancer cells to STS inhibitors was tested using cell growth assays and clonogenic assays. Quantitative reverse transcription-PCR, and Western blotting were performed to detect expression levels of STS and AR. Expression of STS was downregulated using siRNA specific to STS. Stable cell lines overexpression of STS were generated and characterized. Steroid profile including DHEA and androgens was analyzed by Liquid Chromatography-Mass Spectrometry (LC-MS). STS activity was determined by 4-Methylumbelliferyl sulfate assay through a fluorescence microtiter plate reader. PSA secretion was determined by ELISA and PSA-luciferase activity was measured by reporter assay. Eleven potent STS inhibitors were synthesized and characterized. Two novel STS inhibitors in vivo efficacy was tested in castration relapsed VCaP xenograft tumor models. RESULTS: We found STS is overexpressed in CRPC patients and cells. Overexpression of STS in the STS stable expression cells promotes the cellular growth of both LNCaP and C4-2B cells in vitro. Inhibiting STS by siRNA suppresses cell growth and AR signaling. Selected from 11 potential STS inhibitors, two novel small molecule inhibitors (SI-1 and SI-2) inhibit the STS activity and the growth of C4-2B and VCaP cells. SI-1 and SI-2 also significantly suppressed AR transcriptional activity, suggesting that inhibition of STS activity by STS inhibitors downregulates the AR signaling. Additionally, SI-1 and SI-2 significantly suppressed the growth of relapsed VCaP cells and tumors and improved enzalutamide treatment in vitro and in vivo. CONCLUSIONS: STS is involved in castration resistance prostate cancer and inhibition of this enzyme could be a viable strategy to treat CRPC and improve enzalutamide treatment. Source of Funding: NIH CA179970 Sacramento, CA; Clombus, OH; Sacramento, CA© 2019 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetails Volume 201Issue Supplement 4April 2019Page: e981-e981 Advertisement Copyright & Permissions© 2019 by American Urological Association Education and Research, Inc.MetricsAuthor Information Chengfei Liu More articles by this author Liangren Liu More articles by this author Cameron Armstrong* More articles by this author Joy Yang More articles by this author Wei Lou More articles by this author Pui-Kai Li More articles by this author Christopher Evans More articles by this author Allen Gao More articles by this author Expand All Advertisement PDF downloadLoading ..." @default.
• W2940616984 created "2019-05-03" @default.
• W2940616984 creator A5012734277 @default.
• W2940616984 creator A5028546502 @default.
• W2940616984 creator A5040018415 @default.
• W2940616984 creator A5048369552 @default.
• W2940616984 creator A5074725449 @default.
• W2940616984 creator A5086066594 @default.
• W2940616984 creator A5087359161 @default.
• W2940616984 creator A5088621070 @default.
• W2940616984 date "2019-04-01" @default.
• W2940616984 modified "2023-09-23" @default.
• W2940616984 title "MP68-15 TARGETING STEROID SULFATASE SUPPRESSES ANDROGEN RECEPTOR SIGNALING AND TUMOR GROWTH IN CRPC" @default.
• W2940616984 doi "https://doi.org/10.1097/01.ju.0000557030.32825.df" @default.
• W2940616984 hasPublicationYear "2019" @default.
• W2940616984 type Work @default.
• W2940616984 sameAs 2940616984 @default.
• W2940616984 citedByCount "0" @default.
• W2940616984 crossrefType "journal-article" @default.
• W2940616984 hasAuthorship W2940616984A5012734277 @default.
• W2940616984 hasAuthorship W2940616984A5028546502 @default.
• W2940616984 hasAuthorship W2940616984A5040018415 @default.
• W2940616984 hasAuthorship W2940616984A5048369552 @default.
• W2940616984 hasAuthorship W2940616984A5074725449 @default.
• W2940616984 hasAuthorship W2940616984A5086066594 @default.
• W2940616984 hasAuthorship W2940616984A5087359161 @default.
• W2940616984 hasAuthorship W2940616984A5088621070 @default.
• W2940616984 hasBestOaLocation W29406169841 @default.
• W2940616984 hasConcept C117262875 @default.
• W2940616984 hasConcept C121608353 @default.
• W2940616984 hasConcept C126322002 @default.
• W2940616984 hasConcept C134018914 @default.
• W2940616984 hasConcept C1491633281 @default.
• W2940616984 hasConcept C2777911890 @default.
• W2940616984 hasConcept C2778090324 @default.
• W2940616984 hasConcept C2780192828 @default.
• W2940616984 hasConcept C2780902042 @default.
• W2940616984 hasConcept C502942594 @default.
• W2940616984 hasConcept C55493867 @default.
• W2940616984 hasConcept C61367390 @default.
• W2940616984 hasConcept C62112901 @default.
• W2940616984 hasConcept C71315377 @default.
• W2940616984 hasConcept C71924100 @default.
• W2940616984 hasConcept C86803240 @default.
• W2940616984 hasConceptScore W2940616984C117262875 @default.
• W2940616984 hasConceptScore W2940616984C121608353 @default.
• W2940616984 hasConceptScore W2940616984C126322002 @default.
• W2940616984 hasConceptScore W2940616984C134018914 @default.
• W2940616984 hasConceptScore W2940616984C1491633281 @default.
• W2940616984 hasConceptScore W2940616984C2777911890 @default.
• W2940616984 hasConceptScore W2940616984C2778090324 @default.
• W2940616984 hasConceptScore W2940616984C2780192828 @default.
• W2940616984 hasConceptScore W2940616984C2780902042 @default.
• W2940616984 hasConceptScore W2940616984C502942594 @default.
• W2940616984 hasConceptScore W2940616984C55493867 @default.
• W2940616984 hasConceptScore W2940616984C61367390 @default.
• W2940616984 hasConceptScore W2940616984C62112901 @default.
• W2940616984 hasConceptScore W2940616984C71315377 @default.
• W2940616984 hasConceptScore W2940616984C71924100 @default.
• W2940616984 hasConceptScore W2940616984C86803240 @default.
• W2940616984 hasIssue "Supplement 4" @default.
• W2940616984 hasLocation W29406169841 @default.
• W2940616984 hasOpenAccess W2940616984 @default.
• W2940616984 hasPrimaryLocation W29406169841 @default.
• W2940616984 hasRelatedWork W2004261902 @default.
• W2940616984 hasRelatedWork W2014676068 @default.
• W2940616984 hasRelatedWork W2024718203 @default.
• W2940616984 hasRelatedWork W2058317585 @default.
• W2940616984 hasRelatedWork W2068395526 @default.
• W2940616984 hasRelatedWork W2072661483 @default.
• W2940616984 hasRelatedWork W2083291186 @default.
• W2940616984 hasRelatedWork W2103250319 @default.
• W2940616984 hasRelatedWork W2136266902 @default.
• W2940616984 hasRelatedWork W2171723716 @default.
• W2940616984 hasVolume "201" @default.
• W2940616984 isParatext "false" @default.
• W2940616984 isRetracted "false" @default.
• W2940616984 magId "2940616984" @default.
• W2940616984 workType "article" @default.